Ascendance Biotechnology Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Ascendance Biotechnology General Information

Description

Developer of stem cell derived products intended to offer unique cell-based assays. The company's services include application-directed, cellular micro-patterning drug and chemical screening, predictive analysis and basic research, enabling pharmaceutical companies to get basic stem cell research through clinical manufacturing using products that are translatable to the clinic.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly Angel backed
Corporate Office
  • 200 Boston Avenue
  • Suite 1500
  • Medford, MA 02155
  • United States
+1 (781)
Primary Industry
Biotechnology
Acquirer
IVT Holdings
Corporate Office
  • 200 Boston Avenue
  • Suite 1500
  • Medford, MA 02155
  • United States
+1 (781)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ascendance Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 27-Mar-2018 Completed Generating Revenue
2. Angel (individual) 17-May-2016 Completed Startup
1. Angel (individual) 21-Dec-2015 $650K $650K Completed Startup
To view Ascendance Biotechnology’s complete valuation and funding history, request access »

Ascendance Biotechnology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of stem cell derived products intended to offer unique cell-based assays. The company's services include appli
Biotechnology
Medford, MA
2 As of 2016

Tampa, FL
 

Vancouver, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ascendance Biotechnology Competitors (16)

One of Ascendance Biotechnology’s 16 competitors is TransGenex Nanobiotech, a Formerly Accelerator/Incubator backed company based in Tampa, FL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
TransGenex Nanobiotech Formerly Accelerator/Incubator backed Tampa, FL
Aspect Biosystems Venture Capital-Backed Vancouver, Canada
Cellesce Formerly VC-backed Cardiff, United Kingdom
InSphero Venture Capital-Backed Schlieren, Switzerland
Lonza Group Corporation Basel, Switzerland
You’re viewing 5 of 16 competitors. Get the full list »

Ascendance Biotechnology Patents

Ascendance Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10696949-B2 Systems and methods for canine liver modeling Active 26-Jan-2015
US-20160369238-A1 Systems and methods for canine liver modeling Active 26-Jan-2015
US-20160363584-A1 Systems and methods for studying inflammation-drug interactions Inactive 12-Mar-2012
AU-2012207545-B2 Systems and methods for micro-contact stamping Active 21-Jan-2011
CA-2825274-A1 Systems and methods for micro-contact stamping Active 21-Jan-2011 C12M33/02
To view Ascendance Biotechnology’s complete patent history, request access »

Ascendance Biotechnology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ascendance Biotechnology Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
AgeX Therapeutics Corporation Minority
To view Ascendance Biotechnology’s complete investors history, request access »

Ascendance Biotechnology Acquisitions (1)

Ascendance Biotechnology’s most recent deal was a Merger of Equals with Hepregen. The deal was made on 06-Nov-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Hepregen 06-Nov-2015 Merger of Equals Biotechnology
To view Ascendance Biotechnology’s complete acquisitions history, request access »

Ascendance Biotechnology FAQs

  • When was Ascendance Biotechnology founded?

    Ascendance Biotechnology was founded in 2015.

  • Where is Ascendance Biotechnology headquartered?

    Ascendance Biotechnology is headquartered in Medford, MA.

  • What is the size of Ascendance Biotechnology?

    Ascendance Biotechnology has 2 total employees.

  • What industry is Ascendance Biotechnology in?

    Ascendance Biotechnology’s primary industry is Biotechnology.

  • Is Ascendance Biotechnology a private or public company?

    Ascendance Biotechnology is a Private company.

  • What is Ascendance Biotechnology’s current revenue?

    The current revenue for Ascendance Biotechnology is .

  • How much funding has Ascendance Biotechnology raised over time?

    Ascendance Biotechnology has raised $880K.

  • Who are Ascendance Biotechnology’s investors?

    AgeX Therapeutics has invested in Ascendance Biotechnology.

  • Who are Ascendance Biotechnology’s competitors?

    TransGenex Nanobiotech, Aspect Biosystems, Cellesce, InSphero, and Lonza Group are some of the 16 competitors of Ascendance Biotechnology.

  • When was Ascendance Biotechnology acquired?

    Ascendance Biotechnology was acquired on 27-Mar-2018.

  • Who acquired Ascendance Biotechnology?

    Ascendance Biotechnology was acquired by IVT Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »